Table 2.

Patient Demographics and Risk Factors

Candidemic Patients n = 34CoNS Patients
n = 17
Univariate Analysis
P Value
OR (95% Confidence Interval)
Birth weight (g*)1178 (±893)1094 (±589).66
Gestational age (wk*)27.6 (±4.8)28.2 (±3.5).15
Age at diagnosis (d*)24 (±18)31 (±19).19
Intubated (n)32 (94%)11 (65%).018.7 (1,5,49.5)
NPO (n)26 (76%)7 (41%).034.6 (1.3,16)
Antibiotics (# per patient d)1.471.0<.001
Inotropic drugs (% of patient d)37%14%<.001
Systemic steroids (% of patient d)27%13%<.001
Number of patients receiving third-generation cephalosporins29 3 <.00127.1 (5.6,130)
Third-generation cephalosporin use in the 2 wk before diagnosis4.4 d per patient.8 days per patient<.001
Patients who were not on appropriate empiric antimicrobial therapy23 4 <.016.8 (1.8,25.8)
Central catheters at diagnosis (n)33 22
 Broviac1 4
 Percutaneously inserted central catheter16 10
 Umbilical9 1
 Femoral6 4
 Internal jugular1 0
  • * ± standard deviation.